Credo Ventures is a venture capital company focused on early stage investments in Central and Eastern Europe. It is on a mission to identify and back the most interesting early stage companies in the region, support them in their growth plans (including expansion to the U.S. / global market), and help to achieve their objectives. The company is looking for opportunities to invest in high-growth potential companies with international ambitions and competence to execute and deliver. Credo's industry focus is IT, Internet, and health.

Credo Ventures

DigitalHealth.London Accelerator programme is uniquely positioned to provide in-depth knowledge of the NHS to a cohort of high potential small and medium sized businesses (SMEs). The Accelerator aims to speed up the adoption of innovation at scale, ensuring that greater numbers of patients benefit from emerging new technology, more rapidly.  It’s the first programme of its kind, based in London, which draws upon a number of key founding and strategic partners, who together bring a rich and diverse collateral of resources and expertise across healthcare, research, innovation, digital health and tech.

DigitalHealth.London Accelerator

Technology is transforming the way we live, work and play. Loric Ventures invests in innovative and disruptive solutions globally, with a focus on fin- and urbantech and impact.

Loric Ventures

Yabeo Capital focuses on financial purposes and internet related business.

Yabeo

The Guinness Ventures team have been investing in early-stage businesses since 2010. Guinness EIS provides scale-up capital to private companies and Guinness AIM EIS invests in AIM-listed companies. We invest in outstanding entrepreneurs and businesses with disruptive and ambitious growth plans. We have successfully supported the growth of over 100 companies since 2010 and are always excited to meet passionate entrepreneurs.

Guinness Ventures

Kairos is a portfolio of brands across healthcare and financial services that focuses on making life simpler and more affordable for our generation. We start by identifying the toughest problems and build products to solve them. We have built five Kairos solutions to date: Rhino replaces the security deposit, Cera provides affordable care from the comfort of the home, and Little Spoon is a modern parenthood brand to help keep your kid healthy. Bilt is the first rewards program that lets you earn points on rent. Alloy is a new kind of women's health brand. Kairos' 5 brands have a collective market cap of over $2.5bn, and we're currently financing our businesses through our third fund

Kairos HQ

​Earlymarket LLP is a family office with an investment arm dedicated to early-stage technology start-ups. We operate within four themes: the Energy Transition, Future of Agriculture, Personalised Healthcare and IoT & Connectivity themes. We are pro-active and involved as an investor, and from experience we have found the best time to have a meaningful impact is in the early stages of a company. Our spectrum of investment for early stage start-ups is, therefore, from Pre-Seed to Series A.

Earlymarket

Cera

Founded in 2016, Cera is is Europe’s largest provider of digital-first home healthcare, harnessing technology to bring care directly to homes, providing higher quality services at a fraction of the cost. Cera’s 10,000+ carers and nurses provide 60,000 in-person appointments a day, delivering high quality tech-enabled care to the people who need it most.  Cera has also gathered one of the largest home healthcare datasets globally, powering the development of cutting-edge AI products that have reduced hospitalisations by up to 70%. Cera’s pioneering approach has been recognised by numerous industry awards including Home Care Awards’ Most Outstanding Home Care Provider, a top-ten position in Deloitte Fast 50 for three consecutive years, and the prestigious Great British Entrepreneur of the Year award in 2023. Cera was co-founded by entrepreneur, physician and policy expert Dr Ben Maruthappu MBE. Its Advisory Board is Chaired by Sir David Behan, the former CEO of the Care Quality Commission.

England-based Cera provides technology and remote monitoring healthcare solutions to revolutionize the home care industry. Founded in 2016, Cera offers services such as physical and virtual primary care consultations, nursing, prescription delivery services, and remote monitoring. After an initial consultation and patient data collection, the platform monitors and predicts deteriorations in conditions for proactive medical interventions. The company does so by using machine learning, AI, and data analytics.

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

Cera greenlights interconnector project demands

Google Cloud

Cera, a UK-based home healthcare provider, has partnered with Google Cloud to enhance its operational insights and care delivery.

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates.

England-based Cera provides technology and remote monitoring healthcare solutions to revolutionize the home care industry. Founded in 2016, Cera offers services such as physical and virtual primary care consultations, nursing, prescription delivery services, and remote monitoring. After an initial consultation and patient data collection, the platform monitors and predicts deteriorations in conditions for proactive medical interventions. The company does so by using machine learning, AI, and data analytics.The company operates via healthcare providers, offering their services on a B2B2C and B2B basis to help ease provider burdens. The company also enables providers to incorporate Cera's app into healthcare provider's own offering.&nbsp;As of <a href="https://www.cerahq.com/">July 2024</a>, Cera's reach extended across England, Scotland and Wales, with more than 10,000 carers and nurses delivering more than 60,000 in-person care visits every day.Key customers and partnershipsCera has established key partnerships with both public and private sector organizations, including the NHS, the Department for Health &amp; Social Care, IBM, Deliveroo, and Uber. These collaborations aim to improve the quality and accessibility of care. The company also played a key role in the UK government's Join Social Care initiative as a recruitment technology partner to help meet the growing demand for care workers.In <a href="https://www.digitalhealth.net/2024/02/cera-teams-up-with-google-cloud-for-near-instant-insights-into-care/">February 2024</a>, Cera partnered with Google Cloud to enhance its ability to meet home healthcare needs in the UK by providing rapid analytic insights. Through the partnership, Cera was able to offer its caregivers real-time insights that facilitate prompt care interventions by utilizing Google Cloud's advanced data capabilities. The partnership also greatly improved the quality of Cera’s internal datasets, enabling them to reduce hospitalization rates and alleviate the burden on the NHS. It has also sped up insight delivery, producing near-instantaneous reports rather than the previously available 24-hour turnaround. Furthermore, the partnership aided Cera's product development teams in their efforts to consolidate and utilize data for more advanced machine learning capabilities.

Nice healthcare is a virtual and in-home primary care provider that offers a suite of healthcare services to small and medium-sized businesses, including primary care, mental health therapy, and physical therapy. Nice healthcare operates on a fixed monthly fee per member model, allowing employees to access unlimited care without additional out-of-pocket costs. The company provides virtual consultations through its app, as well as in-home visits for physical exams, lab tests, and X-rays.&nbsp;As of <a href="https://www.nice.healthcare/locations">August 2024</a>, Nice Healthcare was operating in 12 states: Arizona, Colorado, Idaho, Iowa, Minnesota, Nebraska, Nevada, New Mexico, Oregon, Utah, Washington, and Wisconsin. The company's services covered <a href="https://www.nice.healthcare/the-nicessities/three-categories-of-primary-care#:~:text=Only%204%25%20of%20our%20patients,with%20Nice%20may%20look%20like.">over 95%</a> of issues patients typically discuss with their clinicians, with <a href="https://www.nice.healthcare/the-nicessities/three-categories-of-primary-care#:~:text=Only%204%25%20of%20our%20patients,with%20Nice%20may%20look%20like.">only 4%</a> of patients being referred to external specialists. The company employs nurse practitioners, registered nurses, physician assistants, and medical assistants to deliver care.As of <a href="https://www.nice.healthcare/the-nicessities/three-categories-of-primary-care">August 2024</a>, Nice healthcare offered 35 free labs and physical tests as well as in-home imaging services and prescribed over 550 free medications that could be picked up at over 60,000 pharmacies nationwide or delivered to patients' homes.&nbsp;Key customers and partnershipsIn <a href="https://www.prnewswire.com/news-releases/getlabs-and-nice-healthcare-partner-to-expand-access-to-virtual-healthcare-services-and-at-home-lab-testing-301813668.html">May 2023</a>, Nice Healthcare announced a partnership with Getlabs, a provider of at-home diagnostic collections. This collaboration aimed to expand access to in-home healthcare services and lab testing, allowing Nice healthcare patients to benefit from a more comprehensive suite of diagnostic tests.

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

Dialogue is a leading virtual care and well-being platform that provides comprehensive health services to organizations and their employees. Founded in 2016, the company offers an integrated health platform that centralizes various health and wellness programs in a single application, accessible <a href="https://www.dialogue.co/en/blog/dialogues-2023-year-in-review#:~:text=Serving%2015%25%20of%20the%20Canadian%20population&amp;text=How%3F,aspects%20of%20their%20well%2Dbeing.">24/7/365</a>. Dialogue's services include primary care, mental health support, employee assistance programs, and wellness initiatives. As of <a href="https://www.dialogue.co/en/blog/dialogues-2023-year-in-review#:~:text=Serving%2015%25%20of%20the%20Canadian%20population&amp;text=How%3F,aspects%20of%20their%20well%2Dbeing.">December 2023</a>, Dialogue's platform was accessible to around 6 million Canadians, representing approximately 15% of the country's population.The company saw significant growth in <a href="https://www.dialogue.co/en/blog/dialogues-2023-year-in-review#:~:text=Serving%2015%25%20of%20the%20Canadian%20population&amp;text=How%3F,aspects%20of%20their%20well%2Dbeing.">December 2023</a>, with a 34% increase in consultations across all aspects of well-being in 2023 compared to the previous year. Mental health consultations, in particular, saw a 67% increase.&nbsp;In <a href="https://www.newswire.ca/news-releases/dialogue-enters-into-license-agreement-with-sun-life-u-s--824463104.html">July 2023</a>, Dialogue was acquired by Sun Life for an undisclosed sum, expanding its reach beyond Canada. This expanded service reach was estimated to cover an additional 600,000 members in the US. The acquisition was completed in <a href="https://www.sunlife.com/en/newsroom/news-releases/announcement/sun-life-completes-the-acquisition-of-dialogue-canadas-premier-health-and-wellness-virtual-care-platform/123792/">October 2023</a>, with Dialogue continuing to operate as a standalone entity.Key customers and partnershipsThe company has partnerships with major insurers and benefits providers to offer its services as part of employee benefits packages. Additionally, the company noted that, as of <a href="https://www.dialogue.co/en/pricing">August 2024</a>, it worked with over 50,000 companies across Canada to provide its services to employees.

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists.

A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app.

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers.

Companies that use GenAI as a core part of their product offering for Telehealth

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

PROMINENT_CATEGORY

<div>

Home healthcare firm, Cera, has established a partnership with Google Cloud to upgrade its capacity to cater to home healthcare requirements in the UK by offering swift analytic insights. This partnership allows Cera to present its caregivers with real-time insights, thereby enabling quick care interventions via Google Cloud's proficient data capabilities.
 The partnership has played a significant role in enhancing the quality of Cera’s internal datasets, helping them to lower hospitalization rates and lessen NHS pressure. It has also minimized insight delivery time, generating nearly on-the-spot reports instead of the earlier 24-hour turnaround. Moreover, this collaboration is beneficial for Cera's product development team as they can better assemble and use data for advanced machine learning capabilities.

</div>

Cera

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless